Portable Medical Oxygen Programme
Development of portable PSA oxygen concentrator platforms, initially focused on 5 LPM and 10 LPM, alongside the manufacturing, quality and lifecycle capability required to support them.
Medical Oxygen →
ZAO₂ Medi develops and participates in controlled programmes spanning medical technology development, healthcare infrastructure, digital health and social impact. Public information is limited to what can be responsibly disclosed.
Project status labels describe the nature of current work. They do not imply completed deployment, regulatory approval or commercial availability.
Development of portable PSA oxygen concentrator platforms, initially focused on 5 LPM and 10 LPM, alongside the manufacturing, quality and lifecycle capability required to support them.
Medical Oxygen →Progressive preparation for regulated local medical-technology manufacturing, including quality-system implementation, verification and validation planning, manufacturing controls and serviceability.
Quality Approach →Development of digital-health capability through Mediflow AI and evaluation of complementary medical technologies relevant to healthcare delivery.
Technology →Development of healthcare infrastructure concepts that strengthen continuity of essential services. Locations, technical configurations, counterparties, financing and other controlled project information are not published.
Associated social-impact work is undertaken through Air of Grace Foundation, with a focus on community healthcare access and outcomes.
Air of Grace Foundation →Projects often involve confidential technical, commercial, regulatory and institutional information. O₂ Medi therefore publishes enough to explain the purpose and maturity of a programme without disclosing information that belongs in controlled discussions or due diligence.
Qualified stakeholders can request further information through the appropriate engagement process.
Engagement is handled on a controlled, context-appropriate basis.